ATE352294T1 - Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen - Google Patents
Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisenInfo
- Publication number
- ATE352294T1 ATE352294T1 AT03722872T AT03722872T ATE352294T1 AT E352294 T1 ATE352294 T1 AT E352294T1 AT 03722872 T AT03722872 T AT 03722872T AT 03722872 T AT03722872 T AT 03722872T AT E352294 T1 ATE352294 T1 AT E352294T1
- Authority
- AT
- Austria
- Prior art keywords
- active ingredients
- therapeutic system
- exhibit different
- transdermal therapeutic
- ingredients contained
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 239000011159 matrix material Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP020101791A AR033748A1 (es) | 2002-05-15 | 2002-05-15 | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE352294T1 true ATE352294T1 (de) | 2007-02-15 |
Family
ID=38561712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03722872T ATE352294T1 (de) | 2002-05-15 | 2003-05-15 | Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen |
Country Status (9)
Country | Link |
---|---|
US (1) | US8017146B2 (de) |
EP (1) | EP1503743B1 (de) |
AR (1) | AR033748A1 (de) |
AT (1) | ATE352294T1 (de) |
AU (1) | AU2003230032A1 (de) |
DE (1) | DE60311449T2 (de) |
ES (1) | ES2281641T3 (de) |
MX (1) | MXPA04011214A (de) |
WO (1) | WO2003097020A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004009903A1 (de) | 2004-02-26 | 2005-09-22 | Grünenthal GmbH | Pflaster mit reduzierter Hautirritation |
US9205062B2 (en) | 2004-03-09 | 2015-12-08 | Mylan Pharmaceuticals, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
US20050202073A1 (en) | 2004-03-09 | 2005-09-15 | Mylan Technologies, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
EP1986618A2 (de) * | 2006-02-13 | 2008-11-05 | Aveva Drug Delivery Systems, Inc. | Sufentanilhaltige haftzubereitung und verfahren zu ihrer anwendung |
DE102006054733A1 (de) | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
US20080160070A1 (en) * | 2006-12-27 | 2008-07-03 | Nexagen Usa Llc | Transdermal vitamin b12 delivery patch |
JP5275047B2 (ja) * | 2007-01-31 | 2013-08-28 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 |
US20090258061A1 (en) * | 2007-10-15 | 2009-10-15 | Johnson & Johnson | Once-a-day replacement transdermal administration of fentanyl |
US20100087768A1 (en) * | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
UA112411C2 (uk) | 2010-03-26 | 2016-09-12 | Філіп Морріс Продактс С.А. | Пригнічення подразнення рецепторів при споживанні бездимних тютюнових виробів |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
JP2013523780A (ja) * | 2010-04-02 | 2013-06-17 | オールトランツ インコーポレイティド | オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑止性経皮製剤 |
WO2013119419A1 (en) | 2012-02-08 | 2013-08-15 | North Carolina State University | Treatment of allergic diseases with recombinant antibodies |
AR095259A1 (es) | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
US10987342B2 (en) | 2013-10-07 | 2021-04-27 | Teikoku Pharma Usa, Inc. | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine |
KR101948779B1 (ko) * | 2013-10-07 | 2019-05-21 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법 |
JP6310070B2 (ja) | 2013-10-07 | 2018-04-11 | テイコク ファーマ ユーエスエー インコーポレーテッド | デクスメデトミジン経皮組成物を用いる、注意欠陥多動性障害、不安症及び不眠症の治療法及び組成物 |
CN107106552A (zh) * | 2014-12-19 | 2017-08-29 | 3M创新有限公司 | 包含芬太尼的透皮药物递送装置 |
WO2018089335A1 (en) | 2016-11-09 | 2018-05-17 | North Carolina State University | Treatment of allergic diseases with chimeric protein |
KR20200024825A (ko) * | 2017-06-08 | 2020-03-09 | 애프리컷 지엠비에이치 | 피부 관리 및 피부 노화 방지를 위한 활성 물질이 포함된 실리콘 패드 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4436741A (en) * | 1975-12-08 | 1984-03-13 | Alza Corporation | Method for administering scopolamine transdermally |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4262003A (en) * | 1975-12-08 | 1981-04-14 | Alza Corporation | Method and therapeutic system for administering scopolamine transdermally |
US4060084A (en) * | 1976-09-07 | 1977-11-29 | Alza Corporation | Method and therapeutic system for providing chemotherapy transdermally |
US4201211A (en) * | 1977-07-12 | 1980-05-06 | Alza Corporation | Therapeutic system for administering clonidine transdermally |
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US5006342A (en) * | 1986-12-22 | 1991-04-09 | Cygnus Corporation | Resilient transdermal drug delivery device |
US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
DE3908432A1 (de) * | 1989-03-14 | 1990-09-27 | Lohmann Therapie Syst Lts | Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung |
DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
DE4223360C1 (de) * | 1992-07-16 | 1993-04-08 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
US5494680A (en) * | 1993-12-08 | 1996-02-27 | Minnesota Mining And Manufacturing Company | Transdermal delivery device |
DE19527925C2 (de) * | 1995-07-29 | 1997-07-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht |
US6174545B1 (en) * | 1997-07-01 | 2001-01-16 | Alza Corporation | Drug delivery devices and process of manufacture |
DE60017831T3 (de) | 1999-01-14 | 2009-12-17 | Noven Pharmaceuticals, Inc., Miami | Dermale zusammensetzungen |
KR20010036685A (ko) | 1999-10-11 | 2001-05-07 | 김윤 | 펜타닐을 함유하는 매트릭스형 경피투여제 |
FR2801507B1 (fr) * | 1999-11-30 | 2003-06-27 | Pf Medicament | Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations |
US20020119187A1 (en) | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
AU2003268376A1 (en) * | 2002-08-30 | 2004-11-26 | Watson Pharmaceuticals, Inc. | Transdermal delivery systems and methods |
-
2002
- 2002-05-15 AR ARP020101791A patent/AR033748A1/es unknown
-
2003
- 2003-05-15 EP EP03722872A patent/EP1503743B1/de not_active Expired - Lifetime
- 2003-05-15 MX MXPA04011214A patent/MXPA04011214A/es active IP Right Grant
- 2003-05-15 US US10/514,047 patent/US8017146B2/en not_active Expired - Fee Related
- 2003-05-15 ES ES03722872T patent/ES2281641T3/es not_active Expired - Lifetime
- 2003-05-15 WO PCT/GB2003/002118 patent/WO2003097020A1/en active IP Right Grant
- 2003-05-15 AU AU2003230032A patent/AU2003230032A1/en not_active Abandoned
- 2003-05-15 AT AT03722872T patent/ATE352294T1/de not_active IP Right Cessation
- 2003-05-15 DE DE60311449T patent/DE60311449T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AR033748A1 (es) | 2004-01-07 |
WO2003097020A1 (en) | 2003-11-27 |
AU2003230032A1 (en) | 2003-12-02 |
MXPA04011214A (es) | 2005-11-04 |
DE60311449T2 (de) | 2007-11-08 |
EP1503743B1 (de) | 2007-01-24 |
ES2281641T3 (es) | 2007-10-01 |
US20050208116A1 (en) | 2005-09-22 |
US8017146B2 (en) | 2011-09-13 |
EP1503743A1 (de) | 2005-02-09 |
DE60311449D1 (de) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE352294T1 (de) | Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen | |
IL183871A0 (en) | Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same | |
DE602004018299D1 (de) | Medizinprodukt mit therapeutischen mitteln | |
HK1077818A1 (en) | Anticholinergic agents, method for producing the same and use thereof as medicaments | |
DE60316552D1 (de) | Tablette mit hohem wirkstoffgehalt | |
ITMI20030562A1 (it) | Abrasivi rivestiti perfezionati, in particolare per | |
HK1103393A1 (en) | Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes | |
DE60308332D1 (de) | Chinazolinverbindungen mit therapeutischem nutzen | |
AT10109U3 (de) | Fentanyl-hältiges, transdermales, therapeutisches system | |
NL1031626A1 (nl) | Verbindingen die bruikbaar zijn in therapie. | |
ES1058674Y (es) | Maquina licuadora perfeccionada. | |
AU2003301405A8 (en) | Prepolymeric materials for site specific delivery to the body | |
ZA200705119B (en) | Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same | |
DE502005003816D1 (de) | System zum Erzeugen von Lenkwinkeln | |
EP1555305A4 (de) | Material für organisches elektrolumineszenzelement sowie davon gebrauch machendes organisches elektrolumineszenzelement | |
DE60306379D1 (de) | Diffusionskontrolliertes wirkstoffabgabesystem mit fluorosiloxan-matrix | |
ITPR20020027A1 (it) | Ampolla nebulizzatrice, in particolare per aerosolterapia. | |
ITMI20030287A1 (it) | Indazolammidi dotate di attivita' analgesica metodo, per | |
DE60305624D1 (de) | Vorrichtung zum Einschränken der Kommunikation abhängig vom Gebiet | |
ITMI20022658A1 (it) | Farmaci per il dolore cronico. | |
AU2003291758A8 (en) | Waxy matrix dosage forms | |
PT1763515E (pt) | Ácidos 4-trifluorometoxifenoxibenzeno-4¿-sulfónicos, processo para a sua preparação e utilização em medicamentos | |
AT500784A3 (de) | Vorrichtung zum herstellen von polsterförmigen, vorzugsweise gefüllten hohlkörpern | |
AU2003278051A8 (en) | Electroluminescent textile structure, in particular for medical use | |
ITMO20020343A0 (it) | Macchina per distribuire bevande. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |